Literature DB >> 24408184

Pregnancy with oocytes characterized by narrow perivitelline space and heterogeneous zona pellucida: is intracytoplasmic sperm injection necessary?

Mei Li1, Shui-Ying Ma, Hui-Jun Yang, Ke-Liang Wu, Wan-Xia Zhong, Guan-Ling Yu, Zi-Jiang Chen.   

Abstract

PURPOSE: This retrospective study analyzed fertilization protocols and pregnancy outcomes for oocytes with with narrow perivitelline space and heterogeneous zona pellucid (NPVS/HZP).
METHODS: In 63 in-vitro fertilization cycles filled with NPVS/HZP oocytes (abnormal oocytes group) and 521 cycles with normal oocytes (normal oocytes group), major clinical and laboratory parameters were recorded and compared in different fertilization cycles (conventional IVF cycles, rescue ICSI cycles, and traditional ICSI cycles).
RESULTS: NPVS/HZP oocytes meant lower MIIoocytes rates in both IVF and ICSI cycles compared with normal oocytes (p < 0.05). The 2PN rates for abnormal oocytes were significantly lower than those for normal oocytes in both conventional IVF cycles (58.8% VS 71.3%, P < 0.05) and rescue ICSI cycles (58.0% VS 78.0%, P = 0.0000). The high-quality embryo rates in normal oocytes groups were significantly higher than those in abnormal oocytes groups in different fertilization cycles (52.2% VS 35.0%, P < 0.01; 42.9% VS 23.9%, P < 0.001; 50.6% VS 31.0%, P = 0.0000, respectively). No clinical pregnancy was obtained from abnormal oocytes in 11 conventional IVF cycles. The clinical pregnancy rates in rescue ICSI and traditional ICSI cycles were comparatively lower in abnormal oocytes groups, but there was no significant difference as compared with normal oocytes groups (35.0% VS 48.1% and 26.7% VS 50.7%, P > 0.05, respectively).
CONCLUSIONS: Retrieval of oocytes characterized by NPVS/PZP from cycle to cycle was one of the reasons for obscure infertility. ICSI may be the right way to avoid fertilization failure and get pregnancy in women with NPVS/HZP oocytes.

Entities:  

Mesh:

Year:  2014        PMID: 24408184      PMCID: PMC3947078          DOI: 10.1007/s10815-013-0169-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  35 in total

1.  First polar body morphology before ICSI is not related to embryo quality or pregnancy rate.

Authors:  P M Ciotti; L Notarangelo; A M Morselli-Labate; V Felletti; E Porcu; S Venturoli
Journal:  Hum Reprod       Date:  2004-09-03       Impact factor: 6.918

2.  Oocyte dysmorphism and aneuploidy in meiotically mature human oocytes after ovarian stimulation.

Authors:  J Van Blerkom; G Henry
Journal:  Hum Reprod       Date:  1992-03       Impact factor: 6.918

3.  Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intracytoplasmic sperm injection.

Authors:  G D Palermo; M Alikani; M Bertoli; L T Colombero; F Moy; J Cohen; Z Rosenwaks
Journal:  Hum Reprod       Date:  1996-01       Impact factor: 6.918

4.  Preliminary observations on polar body extrusion and pronuclear formation in human oocytes using time-lapse video cinematography.

Authors:  D Payne; S P Flaherty; M F Barry; C D Matthews
Journal:  Hum Reprod       Date:  1997-03       Impact factor: 6.918

5.  Polar body fragmentation in IVM oocytes is associated with impaired fertilization and embryo development.

Authors:  B I Rose; D Laky
Journal:  J Assist Reprod Genet       Date:  2013-03-27       Impact factor: 3.412

6.  Tracking of oocyte dysmorphisms for ICSI patients may prove relevant to the outcome in subsequent patient cycles.

Authors:  J S Meriano; J Alexis; S Visram-Zaver; M Cruz; R F Casper
Journal:  Hum Reprod       Date:  2001-10       Impact factor: 6.918

7.  The value of second polar body detection 4 hours after insemination and early rescue ICSI in preventing complete fertilisation failure in patients with borderline semen.

Authors:  Haixia Jin; Yimin Shu; Shanjun Dai; Zhaofeng Peng; Senlin Shi; Yingpu Sun
Journal:  Reprod Fertil Dev       Date:  2014-01       Impact factor: 2.311

8.  Genetic and physiological study of morphologically abnormal human zona pellucida.

Authors:  Michal Margalit; Gedalia Paz; Haim Yavetz; Leah Yogev; Ami Amit; Tamar Hevlin-Schwartz; Satish K Gupta; Sandra E Kleiman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-08-11       Impact factor: 2.435

9.  Rescue ICSI of oocytes that failed to extrude the second polar body 6 h post-insemination in conventional IVF.

Authors:  Christopher Chen; Suresh Kattera
Journal:  Hum Reprod       Date:  2003-10       Impact factor: 6.918

10.  Time-course of oocyte activation, pronucleus formation and cleavage in human oocytes fertilized by intracytoplasmic sperm injection.

Authors:  Z P Nagy; J Liu; H Joris; P Devroey; A Van Steirteghem
Journal:  Hum Reprod       Date:  1994-09       Impact factor: 6.918

View more
  4 in total

1.  Blastulation of a zygote to a hatched blastocyst without any clear cell division: an observational finding in a time-lapse system after in vitro fertilization.

Authors:  N L Sandi-Monroy; S Musanovic; D Zhu; K Eibner; N Reeka; J Koglin; K Bundschu; F Gagsteiger
Journal:  J Assist Reprod Genet       Date:  2020-02-06       Impact factor: 3.412

2.  Embryological Characteristics of Human Oocytes With Agar-Like Zona Pellucida and Its Clinical Treatment Strategy.

Authors:  Dandan Yang; Han Yang; Bo Yang; Kaijuan Wang; Qi Zhu; Jing Wang; Fangfang Ding; Bihua Rao; Rufeng Xue; Jing Peng; Qiushuang Wang; Yunxia Cao; Weiwei Zou; Beili Chen; Zhiguo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

3.  Comparison of the Developmental Potential and Clinical Results of In Vivo Matured Oocytes Cryopreserved with Different Vitrification Media.

Authors:  Mei Li; Miao-Miao Wang; Hui Liu; Ke-Liang Wu; Shui-Ying Ma; Cheng Li; Hai-Bin Zhao; Zi-Jiang Chen
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

4.  Embryological Characteristics and Clinical Outcomes of Oocytes with Heterogeneous Zona Pellucida During Assisted Reproduction Treatment: A Retrospective Study.

Authors:  Chengshuang Pan; Huan Zhang
Journal:  Med Sci Monit       Date:  2020-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.